Aurinia Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA05156V1022

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Michael S Hearne. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Michael S Hearne har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:AUPH / Aurinia Pharmaceuticals Inc. Chief Financial Officer 116.144
US:LJPC / La Jolla Pharmaceutical Co. Chief Financial Officer 0
US:ODT / Odonate Therapeutics Inc Chief Financial Officer 12.767.435
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Michael S Hearne. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AUPH / Aurinia Pharmaceuticals Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AUPH / Aurinia Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Insidersalg AUPH / Aurinia Pharmaceuticals Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AUPH / Aurinia Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Insiderkøb ODTC / Odonate, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AUPH / Aurinia Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-12-23 ODT TANG KEVIN C 63.354 15,4282 63.354 15,4282 977.438 47 27.39 757.828 77,53
2020-12-23 ODT TANG KEVIN C 75.784 15,7080 75.784 15,7080 1.190.415
2020-12-22 ODT TANG KEVIN C 37.856 14,5754 37.856 14,5754 551.766
2020-12-22 ODT TANG KEVIN C 36.646 15,1673 36.646 15,1673 555.821
2020-12-21 ODT TANG KEVIN C 62.144 14,5753 62.144 14,5753 905.767
2020-09-29 ODT TANG KEVIN C 10.882 13,8484 10.882 13,8484 150.698
2020-09-28 ODT TANG KEVIN C 100.000 13,0571 100.000 13,0571 1.305.710
2020-08-28 ODT TANG KEVIN C 1.052.631 14,2500 1.052.631 14,2500 14.999.992
2019-06-26 ODT TANG KEVIN C 769.231 26,0000 769.231 26,0000 20.000.006
2019-06-18 ODT TANG KEVIN C 21.350 26,8862 21.350 26,8862 574.020
2019-06-17 ODT TANG KEVIN C 1.905 26,1999 1.905 26,1999 49.911
2019-06-17 ODT TANG KEVIN C 8.137 26,9535 8.137 26,9535 219.321
2019-06-14 ODT TANG KEVIN C 18.608 24,9513 18.608 24,9513 464.294
2019-06-07 ODT TANG KEVIN C 20.000 26,3110 20.000 26,3110 526.220
2019-06-06 ODT TANG KEVIN C 6.308 27,5579 6.308 27,5579 173.835
2019-06-06 ODT TANG KEVIN C 41.312 27,7052 41.312 27,7052 1.144.557
2019-06-06 ODT TANG KEVIN C 8.688 27,9517 8.688 27,9517 242.844
2019-06-05 ODT TANG KEVIN C 9.972 25,1382 9.972 25,1382 250.678
2019-06-05 ODT TANG KEVIN C 29.484 26,1112 29.484 26,1112 769.863
2019-06-04 ODT TANG KEVIN C 34.714 24,9156 34.714 24,9156 864.920
2019-06-04 ODT TANG KEVIN C 4.236 24,9886 4.236 24,9886 105.852
2019-06-03 ODT TANG KEVIN C 7.859 22,1605 7.859 22,1605 174.159
2019-06-03 ODT TANG KEVIN C 7.427 22,8551 7.427 22,8551 169.745
2019-03-08 ODT TANG KEVIN C 22.863 18,1039 22.863 18,1039 413.909
2019-03-08 ODT TANG KEVIN C 77.137 18,9361 77.137 18,9361 1.460.674
2019-03-07 ODT TANG KEVIN C 19.036 16,5627 19.036 16,5627 315.288
2019-03-07 ODT TANG KEVIN C 964 17,1526 964 17,1526 16.535
2019-03-07 ODT TANG KEVIN C 20.000 17,4955 20.000 17,4955 349.910
2018-12-31 ODT TANG KEVIN C 10.000 13,4201 10.000 13,4201 134.201
2018-12-31 ODT TANG KEVIN C 10.000 13,5070 10.000 13,5070 135.070
2018-12-31 ODT TANG KEVIN C 10.000 13,9866 10.000 13,9866 139.866
2018-12-31 ODT TANG KEVIN C 3.700 13,9978 3.700 13,9978 51.792
2018-12-28 ODT TANG KEVIN C 10.000 12,0394 10.000 12,0394 120.394
2018-12-28 ODT TANG KEVIN C 10.000 13,3469 10.000 13,3469 133.469
2018-12-27 ODT TANG KEVIN C 10.000 12,0315 10.000 12,0315 120.315
2018-12-26 ODT TANG KEVIN C 10.000 12,3966 10.000 12,3966 123.966
2018-12-26 ODT TANG KEVIN C 10.000 12,3384 10.000 12,3384 123.384
2018-12-26 ODT TANG KEVIN C 10.000 12,0937 10.000 12,0937 120.937
2018-12-21 ODT TANG KEVIN C 10.000 12,2731 10.000 12,2731 122.731
2018-12-21 ODT TANG KEVIN C 3.500 12,4364 3.500 12,4364 43.527
2018-12-21 ODT TANG KEVIN C 6.500 13,7799 6.500 13,7799 89.569
2018-12-20 ODT TANG KEVIN C 10.000 13,1742 10.000 13,1742 131.742
2018-12-18 ODT TANG KEVIN C 1.704 15,1770 1.704 15,1770 25.862
2018-12-18 ODT TANG KEVIN C 10.000 14,1327 10.000 14,1327 141.327
2018-12-17 ODT TANG KEVIN C 9.550 14,5070 9.550 14,5070 138.542
2018-12-17 ODT TANG KEVIN C 450 15,2000 450 15,2000 6.840
2018-12-17 ODT TANG KEVIN C 8.296 14,8542 8.296 14,8542 123.230
2018-12-14 ODT TANG KEVIN C 10.000 15,0838 10.000 15,0838 150.838
2018-12-12 ODT TANG KEVIN C 4.550 15,6522 4.550 15,6522 71.218
2018-12-12 ODT TANG KEVIN C 10.000 15,7728 10.000 15,7728 157.728
2018-12-11 ODT TANG KEVIN C 5.450 15,2528 5.450 15,2528 83.128
2018-12-07 ODT TANG KEVIN C 9.500 14,9780 9.500 14,9780 142.291
2018-12-06 ODT TANG KEVIN C 10.000 14,6243 10.000 14,6243 146.243
2018-12-06 ODT TANG KEVIN C 500 14,6598 500 14,6598 7.330

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ODTC / Odonate, Inc. Insider Trades
Insidersalg ODTC / Odonate, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AUPH / Aurinia Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-11-19 ODT TANG KEVIN C 365.289 1,9161 365.289 1,9161 699.930 49 1.0900 -301.765 -43,11
2021-11-18 ODT TANG KEVIN C 212.423 1,9708 212.423 1,9708 418.643
2021-11-18 ODT TANG KEVIN C 500.000 1,8812 500.000 1,8812 940.600
2021-11-18 ODT TANG KEVIN C 381.842 1,8925 381.842 1,8925 722.636
2021-11-17 ODT TANG KEVIN C 468.849 2,6583 468.849 2,6583 1.246.341
2021-11-17 ODT TANG KEVIN C 31.151 1,9941 31.151 1,9941 62.118
2021-11-17 ODT TANG KEVIN C 500.000 2,0161 500.000 2,0161 1.008.050
2021-11-17 ODT TANG KEVIN C 287.577 2,1985 287.577 2,1985 632.238

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ODTC / Odonate, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Michael S Hearne som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-05-20 2026-05-18 4 AUPH Aurinia Pharmaceuticals Inc.
Common Stock
A - Award 116.144 116.144
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
U - Other -9.607.934 0 -100,00 6,23 -59.857.429
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
U - Other -9.607.934 0 -100,00 6,23 -59.857.429
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
D - Sale to Issuer -10.186 0 -100,00 6,23 -63.459
2022-07-05 2022-06-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 236 10.186 2,37 2,71 640 27.619
2022-06-17 2022-06-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 236 9.950 2,43 2,72 642 27.064
2022-06-02 2022-05-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 189 9.714 1,98 3,41 644 33.110
2022-05-17 2022-05-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 188 188
2022-05-17 2022-05-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 188 9.525 2,01 3,41 641 32.466
2022-05-03 2022-04-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 185 185
2022-05-03 2022-04-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 185 9.337 2,02 3,47 642 32.381
2022-04-18 2022-04-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 173 173
2022-04-18 2022-04-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 173 9.152 1,93 3,71 643 33.995
2022-04-04 2022-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 177 177
2022-04-04 2022-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 177 8.979 2,01 3,63 642 32.589
2022-03-17 2022-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 190 190
2022-03-17 2022-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 190 8.802 2,21 3,37 640 29.628
2022-03-02 2022-02-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 185 185
2022-03-02 2022-02-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 185 8.612 2,20 3,48 643 29.940
2022-02-17 2022-02-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 169 169
2022-02-17 2022-02-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 169 8.427 2,05 3,79 641 31.947
2022-02-02 2022-01-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 1.675 1.675
2022-02-02 2022-01-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 1.675 8.258 25,44 3,94 6.592 32.499
2022-01-19 2022-01-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 148 148
2022-01-19 2022-01-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 148 6.583 2,30 4,18 619 27.530
2022-01-14 2022-01-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 78.552 78.552
2022-01-04 2021-12-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 157 157
2022-01-04 2021-12-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 157 6.435 2,50 3,92 615 25.216
2021-12-17 2021-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 173 173
2021-12-17 2021-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 173 6.278 2,83 3,58 619 22.466
2021-12-02 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 186 186
2021-12-02 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 186 6.105 3,14 3,32 617 20.238
2021-12-01 2021-12-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -41.290 9.607.934 -0,43 3,66 -151.303 35.207.313
2021-12-01 2021-12-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -136.255 9.649.224 -1,39 3,76 -512.128 36.267.573
2021-12-01 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -63.745 9.785.479 -0,65 3,95 -251.544 38.614.479
2021-12-01 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -6.597 9.849.224 -0,07 3,95 -26.067 38.918.224
2021-12-01 2021-11-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -193.403 9.855.821 -1,92 4,10 -793.107 40.416.751
2021-11-19 2021-11-19 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -365.289 12.767.435 -2,78 1,92 -699.930 24.463.682
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -381.842 13.132.724 -2,83 1,89 -722.636 24.853.680
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -500.000 13.514.566 -3,57 1,88 -940.600 25.423.602
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -212.423 14.014.566 -1,49 1,97 -418.643 27.619.907
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -287.577 14.226.989 -1,98 2,20 -632.238 31.278.035
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -500.000 14.514.566 -3,33 2,02 -1.008.050 29.262.817
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -31.151 15.014.566 -0,21 1,99 -62.118 29.940.546
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -468.849 15.045.717 -3,02 2,66 -1.246.341 39.996.030
2021-11-17 2021-11-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 181 181
2021-11-17 2021-11-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 181 5.919 3,15 3,41 617 20.175
2021-11-02 2021-10-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 181 181
2021-11-02 2021-10-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 181 5.738 3,26 3,42 618 19.607
2021-10-19 2021-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 183 183
2021-10-19 2021-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 183 5.557 3,41 3,37 616 18.705
2021-10-04 2021-09-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 182 182
2021-10-04 2021-09-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 182 5.374 3,51 3,39 617 18.226
2021-09-17 2021-09-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 546 546
2021-09-17 2021-09-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 546 5.192 11,75 3,39 1.852 17.609
2021-08-03 2021-07-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 201 201
2021-08-03 2021-07-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 201 4.646 4,52 3,07 617 14.256
2021-07-19 2021-07-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 193 193
2021-07-19 2021-07-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 193 4.445 4,54 3,20 617 14.206
2021-07-02 2021-06-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 170 170
2021-07-02 2021-06-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 170 4.252 4,16 3,64 618 15.469
2021-06-17 2021-06-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 148 148
2021-06-17 2021-06-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 148 4.082 3,76 4,16 616 17.002
2021-06-02 2021-05-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 169 169
2021-06-02 2021-05-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 169 3.934 4,49 3,66 618 14.379
2021-06-01 2021-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 43.734 10.049.224 0,44 4,53 198.014 45.499.872
2021-06-01 2021-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 15.358 10.005.490 0,15 4,29 65.917 42.943.563
2021-06-01 2021-05-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 184.642 9.990.132 1,88 4,47 825.978 44.689.856
2021-06-01 2021-05-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1.286 9.805.490 0,01 4,50 5.785 44.109.016
2021-05-26 2021-05-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 166.932 9.804.204 1,73 4,26 710.763 41.744.340
2021-05-26 2021-05-25 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 31.782 9.637.272 0,33 3,83 121.874 36.956.047
2021-05-26 2021-05-25 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 95.597 9.605.490 1,01 3,77 360.860 36.258.804
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 104.403 9.509.893 1,11 3,68 384.234 34.999.259
2021-05-18 2021-05-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 193 193
2021-05-18 2021-05-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 193 3.765 5,40 3,20 617 12.033
2021-05-04 2021-04-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 163 163
2021-05-04 2021-04-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 163 3.572 4,78 3,77 615 13.481
2021-04-19 2021-04-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 173 173
2021-04-19 2021-04-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 173 3.835 4,72 3,55 615 13.626
2021-04-02 2021-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 172 172
2021-04-02 2021-03-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 172 3.662 4,93 3,60 620 13.198
2021-03-17 2021-03-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 37 37
2021-03-17 2021-03-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 37 2.620 1,43 16,22 600 42.496
2021-03-17 2021-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 127 127
2021-03-17 2021-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 127 3.490 3,78 4,85 616 16.939
2021-03-02 2021-02-26 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 34 34
2021-03-02 2021-02-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 34 2.583 1,33 17,89 608 46.210
2021-03-02 2021-02-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 139 139
2021-03-02 2021-02-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 139 3.363 4,31 4,45 619 14.979
2021-02-18 2021-02-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 535 535
2021-02-18 2021-02-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 535 3.224 19,90 5,70 3.051 18.388
2021-02-17 2021-02-12 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 28 28
2021-02-17 2021-02-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 28 2.549 1,11 21,19 593 54.013
2021-02-02 2021-01-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 31 31
2021-02-02 2021-01-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 31 2.521 1,24 19,64 609 49.512
2021-02-02 2020-12-31 4/A LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 1.648 2.435 209,40 3,30 5.435 8.031
2021-02-02 2021-01-15 4/A LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 136 2.571 5,59 4,55 618 11.692
2021-02-02 2021-01-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 118 118
2021-02-02 2021-01-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 118 2.689 4,59 5,20 614 13.988
2021-01-20 2021-01-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 35 35
2021-01-20 2021-01-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 35 2.490 1,43 16,99 595 42.305
2021-01-20 2021-01-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 136 136
2021-01-20 2021-01-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 136 1.094 14,20 4,55 618 4.975
2021-01-05 2020-12-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 350 350
2021-01-05 2020-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 350 2.455 16,63 16,32 5.712 40.066
2021-01-05 2020-12-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 171 171
2021-01-05 2020-12-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 171 958 21,73 3,30 564 3.159
2020-12-23 2020-12-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 75.784 15.514.566 0,49 15,71 1.190.415 243.702.803
2020-12-23 2020-12-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 63.354 15.438.782 0,41 15,43 977.438 238.192.616
2020-12-23 2020-12-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 36.646 15.375.428 0,24 15,17 555.821 233.203.729
2020-12-23 2020-12-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 37.856 15.338.782 0,25 14,58 551.766 223.568.883
2020-12-23 2020-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 62.144 15.300.926 0,41 14,58 905.767 223.015.587
2020-12-17 2020-12-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 43 43
2020-12-17 2020-12-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 43 2.105 2,09 12,91 555 27.176
2020-12-16 2020-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 147 147
2020-12-16 2020-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 147 787 22,97 3,82 562 3.010
2020-12-14 2020-12-10 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 52.191 52.191
2020-12-10 2020-12-08 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22.639 22.639
2020-12-02 2020-11-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 45 45
2020-12-02 2020-11-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 45 2.062 2,23 12,77 575 26.332
2020-12-02 2020-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 134 134
2020-12-02 2020-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 134 640 26,48 4,22 566 2.704
2020-11-17 2020-11-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 141 141
2020-11-17 2020-11-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 141 506 38,63 3,98 561 2.013
2020-11-17 2020-11-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 46 46
2020-11-17 2020-11-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 46 2.017 2,33 12,20 561 24.607
2020-11-05 2020-10-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 196 196
2020-11-05 2020-10-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 196 365 115,98 2,89 566 1.055
2020-11-03 2020-10-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 46 46
2020-11-03 2020-10-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 46 1.971 2,39 12,25 564 24.145
2020-10-19 2020-10-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 42 42
2020-10-19 2020-10-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 42 1.925 2,23 13,35 561 25.699
2020-10-19 2020-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Employee Stock Option (Right to Buy)
A - Award 169 169
2020-10-19 2020-10-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
A - Award 169 169 3,32 561 561
2020-10-02 2020-09-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50 50
2020-10-02 2020-09-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 50 1.883 2,73 11,42 571 21.504
2020-09-30 2020-09-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.882 15.238.782 0,07 13,85 150.698 211.032.749
2020-09-30 2020-09-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 100.000 15.227.900 0,66 13,06 1.305.710 198.832.213
2020-09-17 2020-09-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 43 43
2020-09-17 2020-09-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 43 1.833 2,40 13,06 562 23.939
2020-09-09 2020-09-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 78.369 9.405.490 0,84 4,03 316.047 37.930.460
2020-09-09 2020-09-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 48.296 9.327.121 0,52 4,01 193.894 37.445.593
2020-09-09 2020-09-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 84.152 9.278.825 0,92 3,90 328.529 36.224.533
2020-09-09 2020-09-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 67.552 9.194.673 0,74 3,82 258.359 35.165.946
2020-09-02 2020-08-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 42 42
2020-09-02 2020-08-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 42 1.790 2,40 13,73 577 24.577
2020-09-01 2020-08-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1.052.631 15.127.900 7,48 14,25 14.999.992 215.572.575
2020-08-18 2020-08-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 18 18
2020-08-18 2020-08-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 18 1.748 1,04 30,71 553 53.681
2020-08-14 2020-08-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 168.669 9.127.121 1,88 3,88 653.694 35.373.070
2020-08-14 2020-08-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 219.465 8.958.452 2,51 3,65 800.586 32.679.537
2020-08-14 2020-08-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 43.513 8.738.987 0,50 3,47 150.820 30.290.203
2020-08-04 2020-07-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 18 18
2020-08-04 2020-07-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 18 1.730 1,05 30,91 556 53.474
2020-07-17 2020-07-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17 17
2020-07-17 2020-07-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 17 1.712 1,00 34,99 595 59.903
2020-07-02 2020-06-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 15 15
2020-07-02 2020-06-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 15 1.695 0,89 35,99 540 61.003
2020-06-17 2020-06-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17 17
2020-06-17 2020-06-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 17 1.680 1,02 34,21 582 57.473
2020-06-04 2020-06-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 215.812 8.695.474 2,55 4,94 1.065.636 42.936.512
2020-06-04 2020-06-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 145.764 8.479.662 1,75 4,90 714.783 41.581.719
2020-06-04 2020-06-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 253.553 8.333.898 3,14 4,88 1.237.060 40.660.255
2020-06-03 2020-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 100.000 100.000
2020-06-02 2020-05-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 40 40
2020-06-02 2020-05-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 40 1.663 2,46 27,77 1.111 46.182
2020-05-19 2020-05-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 47 47
2020-05-19 2020-05-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 47 1.623 2,98 24,00 1.128 38.952
2020-05-04 2020-04-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 47 47
2020-05-04 2020-04-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 47 1.576 3,07 23,93 1.125 37.714
2020-04-17 2020-04-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50 50
2020-04-17 2020-04-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 50 1.529 3,38 22,82 1.141 34.892
2020-04-02 2020-03-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 24 24
2020-04-02 2020-03-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 24 1.479 1,65 23,47 563 34.712
2020-03-17 2020-03-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 29 29
2020-03-17 2020-03-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 29 1.455 2,03 19,59 568 28.503
2020-03-03 2020-02-28 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22 22
2020-03-03 2020-02-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 22 1.426 1,57 25,15 553 35.864
2020-02-19 2020-02-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 21 21
2020-02-19 2020-02-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 21 1.404 1,52 26,73 561 37.529
2020-02-04 2020-01-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 23 23
2020-02-04 2020-01-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 23 1.383 1,69 24,82 571 34.326
2020-01-17 2020-01-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 24 24
2020-01-17 2020-01-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 24 1.360 1,80 23,15 556 31.484
2020-01-03 2019-12-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 20 20
2020-01-03 2019-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 20 1.336 1,52 27,58 552 36.847
2019-12-17 2019-12-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22 22
2019-12-17 2019-12-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 22 1.316 1,70 24,62 542 32.400
2019-12-12 2019-12-10 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 32.173 32.173
2019-12-03 2019-11-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 19 19
2019-12-03 2019-11-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 19 1.294 1,49 29,22 555 37.811
2019-11-19 2019-11-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 19 19
2019-11-19 2019-11-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 19 1.275 1,51 28,14 535 35.878
2019-11-04 2019-10-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 21 21
2019-11-04 2019-10-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 21 1.256 1,70 27,00 567 33.912
2019-10-17 2019-10-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 22 22
2019-10-17 2019-10-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 22 1.235 1,81 24,23 533 29.924
2019-10-02 2019-09-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 25 25
2019-10-02 2019-09-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 25 1.213 2,10 22,13 553 26.844
2019-09-17 2019-09-13 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 23 23
2019-09-17 2019-09-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 23 1.188 1,97 24,11 555 28.643
2019-09-04 2019-08-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 21 21
2019-09-04 2019-08-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 21 1.165 1,84 26,19 550 30.511
2019-08-19 2019-08-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 19 19
2019-08-19 2019-08-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 19 1.144 1,69 28,42 540 32.512
2019-08-02 2019-07-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 16 16
2019-08-02 2019-07-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 16 1.125 1,44 34,64 554 38.970
2019-07-17 2019-07-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 18 18
2019-07-17 2019-07-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 18 1.109 1,65 29,89 538 33.148
2019-07-02 2019-06-28 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 17 17
2019-07-02 2019-06-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 17 1.091 1,58 31,19 530 34.028
2019-06-28 2019-06-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 769.231 14.075.269 5,78 26,00 20.000.006 365.956.994
2019-06-18 2019-06-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 26 26
2019-06-18 2019-06-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 26 1.074 2,48 21,25 552 22.822
2019-06-18 2019-06-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 21.350 13.306.038 0,16 26,89 574.020 357.748.799
2019-06-18 2019-06-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8.137 13.284.688 0,06 26,95 219.321 358.068.838
2019-06-18 2019-06-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1.905 13.276.551 0,01 26,20 49.911 347.844.309
2019-06-18 2019-06-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 18.608 13.274.646 0,14 24,95 464.294 331.219.675
2019-06-10 2019-06-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20.000 13.256.038 0,15 26,31 526.220 348.779.616
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8.688 13.236.038 0,07 27,95 242.844 369.969.763
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 41.312 13.227.350 0,31 27,71 1.144.557 366.466.377
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6.308 13.186.038 0,05 27,56 173.835 363.379.517
2019-06-05 2019-06-05 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 29.484 13.179.730 0,22 26,11 769.863 344.138.566
2019-06-05 2019-06-05 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9.972 13.150.246 0,08 25,14 250.678 330.573.514
2019-06-05 2019-06-04 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4.236 13.140.274 0,03 24,99 105.852 328.357.051
2019-06-05 2019-06-04 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 34.714 13.136.038 0,26 24,92 864.920 327.292.268
2019-06-05 2019-06-03 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7.427 13.101.324 0,06 22,86 169.745 299.432.070
2019-06-05 2019-06-03 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7.859 13.093.897 0,06 22,16 174.159 290.167.304
2019-06-04 2019-05-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 30 30
2019-06-04 2019-05-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 30 1.048 2,95 18,27 548 19.147
2019-05-17 2019-05-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 29 29
2019-05-17 2019-05-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 29 1.018 2,93 18,87 547 19.210
2019-05-02 2019-04-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 33 33
2019-05-02 2019-04-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 33 989 3,45 16,71 551 16.526
2019-04-17 2019-04-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 26 26
2019-04-17 2019-04-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 26 956 2,80 21,24 552 20.305
2019-04-02 2019-03-29 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 29 29
2019-04-02 2019-03-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 29 930 3,22 18,79 545 17.475
2019-03-19 2019-03-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 27 27
2019-03-19 2019-03-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 27 901 3,09 20,19 545 18.191
2019-03-11 2019-03-08 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 77.137 13.086.038 0,59 18,94 1.460.674 247.798.524
2019-03-11 2019-03-08 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 22.863 13.008.901 0,18 18,10 413.909 235.511.843
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20.000 12.986.038 0,15 17,50 349.910 227.197.228
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 964 12.966.038 0,01 17,15 16.535 222.401.263
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 19.036 12.965.074 0,15 16,56 315.288 214.736.631
2019-03-04 2019-02-28 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 39 39
2019-03-04 2019-02-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 39 874 4,67 14,01 546 12.245
2019-02-20 2019-02-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 39 39
2019-02-20 2019-02-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 39 835 4,90 14,04 548 11.723
2019-02-04 2019-01-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 38 38
2019-02-04 2019-01-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 38 796 5,01 14,08 535 11.208
2019-01-17 2019-01-15 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 40 40
2019-01-17 2019-01-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 40 758 5,57 13,85 554 10.498
2019-01-03 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 45.045 45.045
2019-01-03 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 45 718 6,69 11,97 539 8.594
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3.700 12.946.038 0,03 14,00 51.792 181.216.051
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.942.338 0,08 13,99 139.866 181.019.305
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.932.338 0,08 13,51 135.070 174.677.089
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.922.338 0,08 13,42 134.201 173.419.068
2018-12-31 2018-12-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.912.338 0,08 13,35 133.469 172.339.684
2018-12-31 2018-12-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.902.338 0,08 12,04 120.394 155.336.408
2018-12-31 2018-12-27 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.892.338 0,08 12,03 120.315 155.114.165
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.882.338 0,08 12,09 120.937 155.795.131
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.872.338 0,08 12,34 123.384 158.824.055
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.862.338 0,08 12,40 123.966 159.449.259
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6.500 12.852.338 0,05 13,78 89.569 177.103.932
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3.500 12.845.838 0,03 12,44 43.527 159.755.980
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.842.338 0,08 12,27 122.731 157.615.299
2018-12-26 2018-12-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.832.338 0,08 13,17 131.742 169.055.787
2018-12-18 2018-12-14 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 42 42
2018-12-18 2018-12-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 42 673 6,66 12,85 540 8.648
2018-12-18 2018-12-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.822.338 0,08 14,13 141.327 181.214.256
2018-12-18 2018-12-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1.704 12.812.338 0,01 15,18 25.862 194.452.854
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8.296 12.810.634 0,06 14,85 123.230 190.291.720
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 450 12.802.338 0,00 15,20 6.840 194.595.538
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9.550 12.801.888 0,07 14,51 138.542 185.716.989
2018-12-18 2018-12-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.792.338 0,08 15,08 150.838 192.957.068
2018-12-13 2018-12-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.782.338 0,08 15,77 157.728 201.613.261
2018-12-13 2018-12-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4.550 12.772.338 0,04 15,65 71.218 199.915.189
2018-12-13 2018-12-11 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 5.450 12.767.788 0,04 15,25 83.128 194.744.517
2018-12-10 2018-12-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9.500 12.762.338 0,07 14,98 142.291 191.154.299
2018-12-10 2018-12-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 500 12.752.838 0,00 14,66 7.330 186.954.055
2018-12-10 2018-12-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10.000 12.752.338 0,08 14,62 146.243 186.494.017
2018-12-04 2018-11-30 4 ODT Odonate Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 40 40
2018-12-04 2018-11-30 4 ODT Odonate Therapeutics, Inc.
Common Stock
A - Award 40 631 6,77 13,40 536 8.455
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
12.743.520
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
25.485.267
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
12.743.520
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
25.485.267
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
12.743.520
2018-11-29 3 ODT Odonate Therapeutics, Inc.
Common Stock
25.485.267
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)